Fang Ni

Insider Reports History

Entity
Individual
Location
C/O Black Diamond Therapeutics, Inc., One Main Street, 10 Th Floor, Cambridge, MA
Signature
/s/ Brent Hatzis-Schoch, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Fang Ni:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Black Diamond Therapeutics, Inc. Officer Title: Chief Business Officer and Chief Financial Officer Stock Option (Right to Buy) 200K Feb 14, 2024 Direct

Insider Reports Filed by Fang Ni

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BDTX Black Diamond Therapeutics, Inc. Feb 14, 2024 1 $0 4 Feb 15, 2024 Officer Title: Chief Business Officer and Chief Financial Officer
BDTX Black Diamond Therapeutics, Inc. Feb 13, 2023 1 $0 4 Feb 15, 2023 Officer Title: Chief Business Officer and interim Chief Financial Officer
BDTX Black Diamond Therapeutics, Inc. Dec 21, 2022 2 $72.4K 4 Dec 23, 2022 Officer Title: Chief Business Officer and interim Chief Financial Officer
BDTX Black Diamond Therapeutics, Inc. Jun 29, 2022 1 $61K 4 Jun 30, 2022 Officer Title: Chief Business Officer and interim Chief Financial Officer
BDTX Black Diamond Therapeutics, Inc. Feb 15, 2022 1 $0 4 Feb 17, 2022 Officer Title: Chief Business Officer and interim Chief Financial Officer
BDTX Black Diamond Therapeutics, Inc. Nov 18, 2021 0 $0 3 Nov 29, 2021 Officer Title: Chief Business Officer and interim Chief Financial Officer